Year started: 2014
My research interests are in exploring differing levels of susceptibility to infectious diseases, with ongoing projects examining genetic susceptibility to severe West Nile and Dengue disease.
Year started: 2016
I am interested in the eco-epidemiology of vector-borne and zoonotic diseases. My previous research includes modeling spatial-temporal risks to viral diseases transmitted by mosquitos in Australia, informing an environmental surveillance system for cholera in India, and studying the responses to West Nile Virus on avian communities in the Midwest United States. At Yale, my current focus is understanding the environmental and social determinants of antimalarial drug resistance transmission in Sub-Saharan Africa.
Year started: 2013
Kelsey Loeliger received her B.S. from the University of Maryland-Baltimore County where she began her research career in an HHMI-affiliated retrovirus laboratory, followed by a post-baccalaureate translational research fellowship at the National Heart, Lung, and Blood Institute. She is currently an M.D./Ph.D. student at the Yale School of Medicine and School of Public Health (Epidemiology of Microbial Diseases). Her international work has assessed how the interplay between substance use, incarceration, HIV, psychiatric disease, violence, and other social circumstances impacts the health of women in Malaysia. She also worked in rural South Africa to identify barriers preventing HIV antiretroviral therapy initiation and adherence. More recently, through the “Seek, Test, Treat, and Retain” Harmonization Consortium funded by the National Institute on Drug Abuse, she worked to identify gender-based differences in HIV risk behaviors in criminal justice-involved individuals. Her current dissertation research, a collaboration with the Connecticut Department of Correction and Department of Public Health, uses big data to track and ultimately improve HIV treatment outcomes after release from jail or prison.
- Loeliger, K.B., Altice, F. L., Desai, M. M., Ciarleglio, M. M., Gallagher, C., Meyer, J. P. Predictors of Linkage to HIV Care and Viral Suppression Levels Following Release from Jails and Prisons (In Press: Lancet HIV)
- Loeliger, K.B., Biggs, M. L., Young, R., Seal, D. W., Beckwith, C. G., Kuo, I., Gordon, M. S., Altice, F. L., Ouellet, L. J., Cunningham, W. E., Young, J. D., Springer, S. A. (2017) Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A Seek, Test, Treat, and Retain Harmonization Consortium. AIDS Behav. doi: 10.1007/s10461-017-1722-9
- Al-Darraji, H. A., Wong, K. C., Yeow, D. G., Fu, J. J., Loeliger, K., Paiji, C., Kamarulzaman, A., Altice, F. L. (2014). Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care. J Subst Abuse Treat, 46(2), 144-149. doi: 10.1016/j.jsat.2013.08.023
- Zhao, Y. O., Kurscheid, S., Zhang, Y., Liu, L., Zhang, L., Loeliger, K., & Fikrig, E. (2012). Enhanced survival of Plasmodium-infected mosquitoes during starvation. PLoS One, 7(7), e40556. doi: 10.1371/journal.pone.0040556
Year started: 2013
Interface between substance abuse and infectious diseases; provision of integrated care to people who suffer from HIV, TB, and HCV co-morbidities; interventions research and implementation science; cost-effectiveness evaluation; regulatory affairs; global health.
- MOROZOVA, O., DVORYAK, S. & ALTICE, F.L. 2013. Methadone Treatment Improves Tuberculosis Treatment Among Hospitalized Opioid Dependent Patients in Ukraine. International Journal of Drug Policy. 24(6): e91-e98.
- MOROZOVA, O., AZBEL, L., GRISHAEV, Y., DVORYAK, S., WICKERSHAM, J. A. & ALTICE, F. L. 2013. Ukrainian Prisoners and Community Reentry Challenges: Implications for Transitional Care. International Journal of Prisoner Health, 9(1): 5-19.
Katharine (Katie) Owers
Year started: 2013
I am interested in applying advanced quantitative methods to questions of disease transmission and natural history in complex ecological settings. My doctoral research applies a variety of spatial and temporal analytical methods to questions about leptospirosis, an environmentally-transmitted zoonotic disease.
Year started: 2016
Alyssa is interested in modeling the impact of public health interventions on mitigating infectious disease spread, particularly among vulnerable populations. Specifically, she seeks to use dynamic transmission models and other mathematical modeling techniques to estimate how climate change affects the spread and intensity of water-borne disease outbreaks in developing countries. Alyssa also intends on quantifying the disproportionate communicable disease burden among climate refugee populations compared to non-refugee populations.
- Parpia AS*, Ndeffo-Mbah ML*, Wenzel NS, Galvani AP. 2016. Impact of response to the 2014-2015 Ebola outbreak on outcomes of malaria, HIV, and tuberculosis, West Africa. Emerging Infectious Diseases. 22(3):433-441. DOI: 10.3201/eid2203.150977.
- Parpia AS, Li Y, Chen C, Dhar B, Crowcroft NS. 2016. Encephalitis, Ontario, Canada, 2002-2013. Emerging Infectious Diseases. 22(3):426-432. DOI: 10.3201/eid2203.151545.
Year started: 2016
Kayoko Shioda, DVM, MPH is a doctoral student in the Department of Epidemiology of Microbial Diseases at Yale. She is interested in using mathematical modeling to advance our understanding of infectious disease dynamics. Her dissertation research focuses on the evaluation of the impact of pneumococcal conjugate vaccines (PCVs) using time series data. She aims to provide quantitative evidence to support decision-making around the adoption and continued use of PCVs in various countries, especially resource-poor settings where the burden of hospitalization and death from pneumonia is greatest. Before starting Ph.D. training, she earned a Doctor of Veterinary Medicine (DVM) from the University of Tokyo in 2012 and MPH from Emory University in 2014. She had worked in the Division of Viral Diseases at the Centers for Disease Control and Prevention in Atlanta, GA as an epidemiology fellow for two years. With her interest in translating evidence into practice, she has also been collaborating with government leaders and working for a start-up company, Blue Industries in Japan.
- Kayoko Shioda, Leslie Barclay, Sylvia Becker-Dreps, Filemon Bucardo-Rivera, Philip Cooper, Daniel C. Payne, Jan Vinjé, Benjamin A. Lopman: Can Use of Viral Load Improve Norovirus Clinical Diagnosis and Disease Attribution? Open forum infectious diseases. 08/2017; 4(3), DOI: 10.1093/ofid/ofx131
- Kayoko Shioda, Leonard Cosmas, Allan Audi, Nicole Gregoricus, Jan Vinjé, Umesh D. Parashar, Joel M. Montgomery, Daniel R. Feikin, Robert F. Breiman, Aron J. Hall: Population-Based Incidence Rates of Diarrheal Disease Associated with Norovirus, Sapovirus, and Astrovirus in Kenya. PLoS ONE 04/2016; 11(4):e0145943., DOI:10.1371/journal.pone.0145943
- Kayoko Shioda, Anita Kambhampati, Aron J Hall, Ben A Lopman: Global age distribution of pediatric norovirus cases. Vaccine 06/2015; 33(33)., DOI:10.1016/j.vaccine.2015.05.051
- Google Scholar: https://scholar.google.com/citations?user=BiawVxEAAAAJ&hl=ja
- ResearchGate: https://www.researchgate.net/profile/Kayoko_Shioda
- LinkedIn: https://www.linkedin.com/in/kayoko-shioda-3ba75795/
Maile Thayer Phillips
Year started: 2017
Maile Thayer Phillips, MS is a PhD candidate at Yale’s Department of Epidemiology of Microbial Diseases. Before Yale, she earned her Master of Science degree in biostatistics from Harvard T. H. Chan School of Public Health in 2017 with a focus on infectious disease epidemiology. Prior to receiving her Masters, Phillips served in the United States Peace Corps in Sierra Leone where she worked on projects with malaria. In addition to West Africa, she has also worked in Peru, Guatemala, Honduras, Nicaragua, and Brazil. She is interested in employing a variety of mathematical modeling techniques to contribute to the field of infectious disease dynamics. Phillips has been involved in projects across the globe focusing on malaria, Ebola virus, Zika virus, Leishmaniasis, Staphylococcus aureus, and pneumococcus.